Physician profile
Brian E Mccarthy
NPI 1558370395
$832.77
in general payments reported to CMS, 2019-2025
11 companies · $55.10 in 2025
The $55.10 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.16 · 2020: $166 · 2021: $64.22 · 2022: $28.62 · 2024: $469 · 2025: $55.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $249.62 | 2024-2025 | Mazor X System, Inceptiv |
| Cardiovascular Systems INC. | $126.48 | 2020 | |
| Bioventus LLC | $85.74 | 2024 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $83.79 | 2019-2024 | Prostep Mica |
| Nevro Corp. | $81.03 | 2021-2022 | |
| Cgg Medical INC | $53.88 | 2024 | |
| Zyla Life Sciences, INC. | $39.68 | 2020 | |
| Smith+Nephew, INC. | $37.20 | 2024 | Iodosorb Ointment 40g USA, Regranex, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $35.11 | 2024 | Nuzyra |
| Amgen INC. | $28.43 | 2025 | Krystexxa |
| Abbvie INC. | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.